Hafnia Limited (HAFN) Surpasses Q2 Earnings Estimates — Positive

HAFN   Zacks Investment Research — August 27, 2025

Hafnia Limited (HAFN) came out with quarterly earnings of $0.15 per share, beating the Zacks Consensus Estimate of $0.14 per share. This compares to earnings of $0.51 per share a year ago.

image for news Hafnia Limited (HAFN) Surpasses Q2 Earnings Estimates

Gold price weaker as USDX rallies — Negative

AAAU  BAR  DBP  DGL  GLD  GLDM  IAU  OUNZ  SGOL  UGL   Kitco — August 27, 2025

Jim Wyckoff has spent over 25 years involved with the stock, financial and commodity markets. He was a financial journalist with the FWN newswire service for many years, including stints as a reporter on the rough-and-tumble commodity futures trading floors in Chicago and New York.

image for news Gold price weaker as USDX rallies

Ford is recalling another 356,000 cars. This time to fix an instrument panel display.

image for news Ford Stock Wobbles. Why Its Latest Recall Is Stoking Quality Concerns.

Sompo to Acquire Aspen for $3.5 Billion — Neutral

AHL   GlobeNewsWire — August 27, 2025

All outstanding Class A ordinary shares of Aspen to be redeemed for cash and delisted from NYSE; Aspen preference shares to remain outstanding

image for news Sompo to Acquire Aspen for $3.5 Billion

On July 15, 2025, Encompass stock fell 10.4% to $107.28 after a NYT report revealed poor safety, high readmissions, and fatal errors at its hospitals.

image for news ENCOMPASS INVESTIGATION ALERT: Bragar Eagel & Squire, P.C. is Continuing Investigating Encompass Health Corporation on Behalf of Encompass Stockholders and Encourages Investors to Contact the Firm

Presenting Data from CLOVER-2 Phase 1 Clinical Study Evaluating Iopofosine I 131 in Relapsed/Refractory Pediatric High-Grade Glioma (r/r pHGG) Patients Presenting Data from CLOVER-2 Phase 1 Clinical Study Evaluating Iopofosine I 131 in Relapsed/Refractory Pediatric High-Grade Glioma (r/r pHGG) Patients

image for news Cellectar Biosciences to Present Data in Oral Session and Panel Discussions at the American Association for Cancer Research Special Conference on Discovery and Innovation in Pediatric Cancer

DANBURY, Conn. and BOSTON, Aug. 27, 2025 (GLOBE NEWSWIRE) -- MannKind Corporation (Nasdaq: MNKD) today announced that United Therapeutics Corporation (Nasdaq: UTHR) has exercised its option—granted under the companies' 2018 license and collaboration agreement—to develop a second dry powder inhalation therapy.

image for news MannKind Announces Expansion of United Therapeutics Collaboration for Second Inhaled Therapy

Wall Street Breakfast Podcast: Futures Flat Awaiting Nvidia Earnings — Neutral

CRWD  HPQ  INDU  META  MSFT  NVDA  SNOW  TSLA   Seeking Alpha — August 27, 2025

Markets are flat as investors await Nvidia's earnings, with expectations of strong AI-driven growth fueling anticipation. Trump's attempt to remove Fed Governor Lisa Cook raises concerns about central bank independence and could signal a shift favoring small-cap stocks.

image for news Wall Street Breakfast Podcast: Futures Flat Awaiting Nvidia Earnings

Spot Outliers Like Agnico Eagle Before They Fly High — Positive

AEM   FXEmpire — August 27, 2025

Agnico Eagle Mines Limited (AEM) up 1,004% since Big Money bought big in September 2002.

image for news Spot Outliers Like Agnico Eagle Before They Fly High

WILMINGTON, Del., Aug. 27, 2025 (GLOBE NEWSWIRE) -- NRx Pharmaceuticals, Inc. (Nasdaq:NRXP), a clinical-stage biopharmaceutical company, today announced its expanded access policy for NRX-100 (preservative-free ketamine) based on grant of Fast Track designation for NRX-100 in the treatment of suicidal ideation in patients with depression, including bipolar depression.

image for news NRx Pharmaceuticals, Inc. (NASDAQ:NRXP) Announces Expanded Access Policy for NRX-100 (preservative-free ketamine)

DevvStream Regains Compliance with Nasdaq Listing Requirements — Neutral

DEVS   Newsfile Corp — August 27, 2025

Calgary, Alberta--(Newsfile Corp. - August 27, 2025) - DevvStream Corp. (NASDAQ: DEVS) (the "Company"), a leading carbon management firm specializing in the development, investment, and sale of environmental assets, today announced that on August 22, 2025, it received a notice from The Nasdaq Stock Market, LLC (the "Nasdaq") notifying the Company that it has regained compliance with Nasdaq Listing Rule 5550(a)(2) and that its common shares, with no par value (the "Common Shares"), continue to be listed and traded on The Nasdaq Capital Market. As previously disclosed, the Company received a staff determination from Nasdaq stating that the bid price …

image for news DevvStream Regains Compliance with Nasdaq Listing Requirements

MongoDB Stock Soars After Earnings. Why It Looks Like an AI Winner. — Positive

MDB   Barrons — August 27, 2025

MongoDB's latest earnings suggest the risk of losing database market share in the artificial-intelligence era might be overblown.

image for news MongoDB Stock Soars After Earnings. Why It Looks Like an AI Winner.

AUSTIN, Texas--(BUSINESS WIRE)--CrowdStrike (NASDAQ: CRWD) today announced it has been named a Leader in the IDC MarketScape: Worldwide Incident Response Services Vendor Assessment. Adversaries are now weaponizing AI to scale operations, accelerate attacks, and target the very AI systems and autonomous agents that are reshaping enterprise environments. Defending against this new era of threats demands partners with deep incident response experience, real-time visibility across diverse systems,.

image for news CrowdStrike Named a Leader in 2025 IDC MarketScape for Worldwide Incident Response Services

Abercrombie & Fitch narrowly beat Wall Street's expectations thanks to strong growth at its teen-focused Hollister brand. The company's namesake brand's sales fell 5%, while Hollister grew 19%.

image for news Abercrombie sales growth slows again, but Hollister surges 19%

Emergent BioSolutions to Participate in Upcoming Investor Conferences — Neutral

EBS   GlobeNewsWire — August 27, 2025

GAITHERSBURG, Md., Aug. 27, 2025 (GLOBE NEWSWIRE) -- Emergent BioSolutions Inc. (NYSE: EBS) announced today that members of the company's senior management team will participate in the following investor conferences: Wells Fargo 20 th Annual Healthcare Conference September 4, 20253:00 pm ETWebcast link here One-on-one meetings HCW 27 th Annual Global Investment Conference September 9, 20251:30 PM ETWebcast link here One-on-one meetings Please contact your conference representative to request one-on-one meetings.

image for news Emergent BioSolutions to Participate in Upcoming Investor Conferences

Bragar Eagel & Squire, P.C. Litigation Partner Brandon Walker Encourages Investors Who Suffered Losses In BellRing Brands (BRBR) To Contact Him Directly To Discuss Their Options If you purchased or acquired securities in BellRing Brands and would like to discuss your legal rights, call Bragar Eagel & Squire partner Brandon Walker or Marion Passmore directly at (212) 355-4648.

image for news BRBR INVESTIGATION ALERT: Bragar Eagel & Squire, P.C. Continues Investigation on Behalf of BellRing Brands Inc. Investors

BOULDER, Colo. , Aug. 27, 2025 /PRNewswire/ -- Canopy USA, LLC ("Canopy USA"), a brand-driven organization strategically positioned across the U.S. cannabis market, today announced the appointment of Eric Ruhle as Vice President of Brand Sales, overseeing sales strategy across the full Canopy USA portfolio.

image for news Canopy USA Welcomes Cannabis Veteran Eric Ruhle as New Vice President of Brand Sales

Shares of Nvidia Corp. (NASDAQ: NVDA) have surged 38.4% over the past 90 days, including a 3.6% pop in the past week ahead of its earnings report.

image for news Nvidia (NASDAQ: NVDA) Stock Price Prediction for 2025: Where Will It Be in 1 Year (Aug 27)

Updates include AI-enabled EHR interoperability, comprehensive data collection, and safety integration capabilities AUSTIN, Texas , Aug. 27, 2025 /PRNewswire/ -- Oracle today introduced significant advancements to its Electronic Data Capture (EDC) solution, Oracle Clinical One Data Collection. These new capabilities enable seamless interoperability with Electronic Health Record (EHR) systems, enhance data collection capabilities at trial sites, and provide end-to-end integration with Oracle Safety One Argus and other safety solutions.

image for news Oracle Enhances Electronic Data Capture Solution to Streamline Clinical Trials and Help Bring New Therapies to Market Faster

MIMEDX to Participate in Upcoming Investor Conferences — Neutral

MDXG   GlobeNewsWire — August 27, 2025

MARIETTA, Ga., Aug. 27, 2025 (GLOBE NEWSWIRE) -- MiMedx Group, Inc. (Nasdaq: MDXG) (“MIMEDX” or the “Company”) today announced that members of its senior management will participate in the following investor conferences:

image for news MIMEDX to Participate in Upcoming Investor Conferences